{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:39:01Z","timestamp":1792791541701,"version":"4.5.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuropharm.2026.111199","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:12:09Z","timestamp":1790377929000},"page":"111199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A synthetic benzothiazole\u2013thiourea derivative with multi-target potential activity for Alzheimer's disease: Antioxidant properties and mechanistic insights"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5809-8405","authenticated-orcid":false,"given":"Asma","family":"Lahouel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Harrouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercan","family":"Oguz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikret","family":"T\u00fcrkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4838-1503","authenticated-orcid":false,"given":"Adnan","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7343-0242","authenticated-orcid":false,"given":"Smail","family":"Khelili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.neuropharm.2026.111199_bib1","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1139\/v89-190","article-title":"Kinetic study of the oxidation mechanism of glutathione by hydrogen peroxide in neutral aqueous medium","volume":"67","author":"Abedinzadeh","year":"1989","journal-title":"Can. J. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111199_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1570159X113116660047","article-title":"Multi-target-directed ligands and other therapeutic strategies in the search of a real solution for Alzheimer's disease","volume":"12","author":"Agis-Torres","year":"2014","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111199_bib3","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1038\/s41598-023-34382-7","article-title":"Stopped-flow DPPH\u2022 kinetic method","volume":"13","author":"Angeli","year":"2023","journal-title":"Sci. Rep."},{"issue":"8081","key":"10.1016\/j.neuropharm.2026.111199_bib4","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41586-025-09335-x","article-title":"Lithium deficiency and the onset of Alzheimer's disease","volume":"645","author":"Aron","year":"2025","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111199_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jmb.2003.08.031","article-title":"Structural characterization of the GSK-3\u03b2 active site using selective and non-selective ATP-mimetic inhibitors","volume":"333","author":"Bertrand","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2026.111199_bib6","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1007\/s12035-019-1563-9","article-title":"Molecular targets in Alzheimer's disease","volume":"56","author":"Bj\u00f8rklund","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111199_bib7","article-title":"Synthesis and exploration of antibacterial activity, molecular docking, and DFT studies of some benzothiazole\u2013urea (thiourea) hybrid compounds","volume":"10","author":"Bouider","year":"2025","journal-title":"ChemSelect"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2026.111199_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111199_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0023-6438(95)80008-5","article-title":"Use of a free radical method to evaluate antioxidant activity","volume":"28","author":"Brand-Williams","year":"1995","journal-title":"LWT Food Sci. Technol."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111199_bib10","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1016\/j.arabjc.2016.02.004","article-title":"Evaluation of a new benzothiazole derivative with antioxidant activity in the initial phase of acetaminophen toxicity","volume":"12","author":"Cabrera-Perez","year":"2019","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.neuropharm.2026.111199_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejmech.2018.08.005","article-title":"Donepezil-butylated hydroxytoluene (BHT) hybrids as anti-Alzheimer\u2019s disease agents with cholinergic, antioxidant, and neuroprotective properties","volume":"157","author":"Cai","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111199_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(99)00908-5","article-title":"Nimesulide limits kainate-induced oxidative damage in the rat hippocampus","volume":"390","author":"Candelario-Jalil","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111199_bib13","article-title":"Synthesis of 4-diazocyclohexane-based sulfonamide drug scaffolds: investigating enzyme inhibition, antioxidant, and ADMET properties","volume":"1332","author":"Cetin","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111199_bib14","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s00044-022-02974-z","article-title":"Synthesis, biological evaluation, and bioinformatics analysis of indole analogs on AChE and GST activities","volume":"31","author":"Cetin","year":"2022","journal-title":"Med. Chem. Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111199_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02815097","article-title":"The effects of oxidative stress on in vivo brain GSH turnover in young and mature mice","volume":"30","author":"Chang","year":"1997","journal-title":"Mol. Chem. Neuropathol."},{"issue":"22","key":"10.1016\/j.neuropharm.2026.111199_bib16","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1002\/anie.201610402","article-title":"On the reactions of thiols, sulfenic acids, and sulfinic acids with hydrogen peroxide","volume":"56","author":"Chauvin","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.neuropharm.2026.111199_bib17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.redox.2018.01.008","article-title":"13 reasons why the brain is susceptible to oxidative stress","volume":"15","author":"Cobley","year":"2018","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111199_bib18","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"W1","key":"10.1016\/j.neuropharm.2026.111199_bib19","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111199_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.apsb.2024.10.004","article-title":"Oxidative stress and inflammation in the pathogenesis of neurological disorders: mechanisms and implications","volume":"15","author":"Dash","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"35","key":"10.1016\/j.neuropharm.2026.111199_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202502666","article-title":"Urea based derivatives as anticancer agents: cytotoxicity, GST inhibition, molecular docking, ADME, and molecular dynamics approaches","volume":"10","author":"Demir","year":"2025","journal-title":"ChemistrySelect"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111199_bib22","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1016\/j.bbagen.2012.09.018","article-title":"Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes","volume":"1830","author":"Deponte","year":"2013","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"18","key":"10.1016\/j.neuropharm.2026.111199_bib23","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1080\/07391102.2020.1805362","article-title":"Screening of potential drug for Alzheimer's disease: a computational study with GSK-3\u03b2 inhibition through virtual screening, docking, and molecular dynamics simulation","volume":"39","author":"Elangovan","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111199_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111199_bib25","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0891-5849(02)00850-X","article-title":"Kinetics of the reactions of nitrogen dioxide with glutathione, cysteine, and uric acid at physiological pH","volume":"32","author":"Ford","year":"2002","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111199_bib26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.35772\/ghm.2024.01033","article-title":"BACE1 inhibitor drugs for the treatment of Alzheimer's disease: lessons learned, challenges to overcome, and future prospects","volume":"6","author":"Ghosh","year":"2024","journal-title":"Global Health Med."},{"key":"10.1016\/j.neuropharm.2026.111199_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/bs.ircmb.2018.05.006","article-title":"Mitochondria and reactive oxygen species in aging and age-related diseases","volume":"340","author":"Giorgi","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"S1","key":"10.1016\/j.neuropharm.2026.111199_bib28","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1096\/fasebj.2019.33.1_supplement.642.4","article-title":"Ensemble docking of potential BACE1 inhibitors for Alzheimer's disease","volume":"33","author":"Guevara","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2026.111199_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.127660","article-title":"Computational screening of promising beta-secretase 1 inhibitors through multi-step molecular docking and molecular dynamics simulations\u2014pharmacoinformatics approach","volume":"1205","author":"Gupta","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.neuropharm.2026.111199_bib30","series-title":"U.S. Patent 6,835,811","author":"Harbin","year":"2004"},{"key":"10.1016\/j.neuropharm.2026.111199_bib31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ejmech.2016.03.028","article-title":"Synthesis, characterization and biological evaluation of benzothiazoles and tetrahydrobenzothiazoles bearing urea or thiourea moieties as vasorelaxants and inhibitors of the insulin releasing process","volume":"115","author":"Harrouche","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111199_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2023.1200490","article-title":"Identifying promising GSK3\u03b2 inhibitors for cancer management: a computational pipeline combining virtual screening and molecular dynamics simulations","volume":"11","author":"Hua","year":"2023","journal-title":"Front. Chem."},{"key":"10.1016\/j.neuropharm.2026.111199_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101503","article-title":"A promising acetylcholinesterase and butyrylcholinesterase inhibitors: in vitro enzymatic and in silico molecular docking studies of benzothiazole-based oxadiazole containing imidazopyridine hybrid derivatives","volume":"7","author":"Hussain","year":"2024","journal-title":"Results Chem."},{"issue":"15","key":"10.1016\/j.neuropharm.2026.111199_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202505804","article-title":"Green synthesis of tetrahydrodipyrazolopyridines: in silico and in vitro evaluation against HepG2 liver cancer cells","volume":"11","author":"\u0130lik","year":"2026","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.neuropharm.2026.111199_bib35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.07.014","article-title":"Emerging roles of oxidative stress in brain aging and Alzheimer's disease","volume":"107","author":"Ionescu-Tucker","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111199_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/138161206775193127","article-title":"The peripheral anionic site of acetylcholinesterase: structure, functions and potential role in rational drug design","volume":"12","author":"Johnson","year":"2006","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111199_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/emm.1997.26","article-title":"Hemin inhibits lipid peroxidation induced by ascorbate\/FeSO4 and 2,2\u2032-azobis-2-amidino-propane hydrochloride (ABAP)","volume":"29","author":"Jung","year":"1997","journal-title":"Exp. Mol. Med."},{"issue":"36","key":"10.1016\/j.neuropharm.2026.111199_bib38","doi-asserted-by":"crossref","first-page":"23626","DOI":"10.1039\/D2RA03803J","article-title":"Gundogdu-Karaburun, N. Synthesis of novel benzothiazole derivatives and investigation of their enzyme inhibitory effects against Alzheimer's disease","volume":"12","author":"Karaca","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.neuropharm.2026.111199_bib39","series-title":"Polypharmacology: Strategies for Multi-Target Drug Discovery","first-page":"61","article-title":"Kinase liabilities in early drug discovery","author":"Kirchner","year":"2024"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111199_bib40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/07391102.2015.1022603","article-title":"Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis","volume":"34","author":"Kumar","year":"2016","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.neuropharm.2026.111199_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116742","article-title":"Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease","volume":"61","author":"Kumar","year":"2022","journal-title":"Bioorg. Med. Chem."},{"issue":"W1","key":"10.1016\/j.neuropharm.2026.111199_bib42","doi-asserted-by":"crossref","first-page":"W338","DOI":"10.1093\/nar\/gky356","article-title":"CABS-flex 2.0: a web server for fast simulations of flexibility of protein structures","volume":"46","author":"Kuriata","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111199_bib43","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0031-9384(90)90364-A","article-title":"Age-related changes in spontaneous behavior and learning in NMRI mice from maturity to middle age","volume":"47","author":"Lamberty","year":"1990","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111199_bib44","article-title":"The acetylation of cyclin-dependent kinase 5 at lysine 33 regulates kinase activity and neurite length in hippocampal neurons","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111199_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","article-title":"History and progress of hypotheses and clinical trials for Alzheimer's disease","volume":"4","author":"Liu","year":"2019","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"18","key":"10.1016\/j.neuropharm.2026.111199_bib46","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1016\/j.bmcl.2012.07.068","article-title":"Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (CDK5)\/p25 inhibitors","volume":"22","author":"Malmstr\u00f6m","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111199_bib47","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/jm049323m","article-title":"Mechanism of CDK5\/p25 binding by CDK inhibitors","volume":"48","author":"Mapelli","year":"2005","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111199_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119264","article-title":"Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis","volume":"10","author":"Mart\u00ednez","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111199_bib49","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbadis.2011.10.006","article-title":"Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease","volume":"1822","author":"Mecocci","year":"2012","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111199_bib50","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/14756366.2018.1443326","article-title":"Profiling donepezil template into multipotent hybrids with antioxidant properties","volume":"33","author":"Mezeiova","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.111199_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116484","article-title":"Multitarget action of benzothiazole-piperazine small hybrid molecule against Alzheimer's disease: in silico, in vitro, and in vivo investigation","volume":"174","author":"Mishra","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111199_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13721-018-0177-x","article-title":"Computational simulation of inhibitory effects of curcumin, retinoic acid and their conjugates on GSK-3\u03b2","volume":"8","author":"Mishra","year":"2019","journal-title":"Netw. Model. Anal. Health Inform. Bioinform."},{"key":"10.1016\/j.neuropharm.2026.111199_bib53","article-title":"Therapeutic time window for edaravone treatment of traumatic brain injury in mice","volume":"1","author":"Miyamoto","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.neuropharm.2026.111199_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.107981","article-title":"Computational evidence of new putative allosteric sites in the acetylcholinesterase receptor","volume":"107","author":"Moghadam","year":"2021","journal-title":"J. Mol. Graph. Model."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111199_bib55","doi-asserted-by":"crossref","first-page":"9834","DOI":"10.1002\/fsn3.4548","article-title":"The impact of vitamin E supplementation on oxidative stress, cognitive functions, and aging\u2010related gene expression in aged mice","volume":"12","author":"Molavi Vasei","year":"2024","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.neuropharm.2026.111199_bib56","doi-asserted-by":"crossref","DOI":"10.2174\/0115734064337582241103172720","article-title":"Promising anticancer activity of pyrazole compounds against glioblastoma multiforme: their synthesis, in vitro, and molecular docking studies","author":"Nalc\u0131","year":"2025","journal-title":"Med. Chem."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111199_bib57","doi-asserted-by":"crossref","first-page":"10835","DOI":"10.1021\/acsomega.4c06760","article-title":"Synthesis, formation mechanisms, and molecular dynamics simulation of novel benzothiazole and benzo [1,4] oxazin-3(4H)-one as potential acetylcholinesterase inhibitors","volume":"10","author":"Nguyen","year":"2025","journal-title":"ACS Omega"},{"issue":"3s","key":"10.1016\/j.neuropharm.2026.111199_bib58","doi-asserted-by":"crossref","first-page":"S704","DOI":"10.5530\/ijper.58.3s.74","article-title":"Synthesis and pharmacological activities of benzothiazole derivatives","volume":"58","author":"Nishad","year":"2024","journal-title":"Indian J. Pharm. Educ. Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111199_bib59","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.ajog.2005.03.069","article-title":"Free radical scavenger, edaravone, inhibits lipid peroxidation and the production of nitric oxide in hypoxic-ischemic brain damage of neonatal rats","volume":"193","author":"Noor","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111199_bib60","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"issue":"44","key":"10.1016\/j.neuropharm.2026.111199_bib61","article-title":"A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease","volume":"1","author":"Pathak","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111199_bib62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1152\/physrev.00030.2022","article-title":"Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease","volume":"104","author":"Perluigi","year":"2024","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111199_bib63","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.compbiomed.2011.10.014","article-title":"Cyclin-dependent kinases 5 template: useful for virtual screening","volume":"42","author":"Pitchuanchom","year":"2012","journal-title":"Comput. Biol. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111199_bib64","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/biology11020212","article-title":"Antioxidants in Alzheimer's disease: current therapeutic significance and future prospects","volume":"11","author":"Pritam","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.neuropharm.2026.111199_bib65","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fpls.2013.00477","article-title":"Missing links in understanding redox signaling via thiol\/disulfide modulation: how is glutathione oxidized in plants?","volume":"4","author":"Rahantaniaina","year":"2013","journal-title":"Front. Plant Sci."},{"issue":"9\u201310","key":"10.1016\/j.neuropharm.2026.111199_bib66","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0891-5849(98)00315-3","article-title":"Antioxidant activity applying an improved ABTS radical cation decolorization assay","volume":"26","author":"Re","year":"1999","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111199_bib67","article-title":"Cerebral mitochondrial function and cognitive performance during aging: a longitudinal study in NMRI mice","volume":"2020","author":"Reutzel","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"21","key":"10.1016\/j.neuropharm.2026.111199_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112945","article-title":"In silico and in vitro studies of benzothiazole-isothioureas derivatives as a multitarget compound for Alzheimer's disease","volume":"23","author":"Rosales Hern\u00e1ndez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111199_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400182","article-title":"Synthesis and examination of 1,2,4-triazine-sulfonamide hybrids as potential inhibitory drugs: inhibition effects on AChE and GST enzymes in silico and in vitro conditions","volume":"357","author":"Rozbicki","year":"2024","journal-title":"Arch Pharm (Weinheim)"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111199_bib70","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/carcin\/10.6.1003","article-title":"Prevention of cytotoxicity and inhibition of intercellular communication by antioxidant catechins isolated from Chinese green tea","volume":"10","author":"Ruch","year":"1989","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111199_bib71","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ibneur.2024.07.004","article-title":"Reduced ischemia\u2010reperfusion oxidative stress injury by melatonin and N\u2010acetylcysteine in the male rat brain","volume":"17","author":"Sabbaghziarani","year":"2024","journal-title":"IBRO Neurosci. Rep."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111199_bib72","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2174\/1389450122666210120143953","article-title":"Recent advances in the discovery of GSK-3 inhibitors from synthetic origin in the treatment of neurological disorders","volume":"22","author":"Saha","year":"2021","journal-title":"Curr. Drug Targets"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111199_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad577","article-title":"A machine learning-based quantitative model (LogBB_Pred) to predict the blood\u2013brain barrier permeability (logBB value) of drug compounds","volume":"39","author":"Shaker","year":"2023","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111199_bib74","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/bioinformatics\/btaa918","article-title":"LightBBB: computational prediction model of blood\u2013brain-barrier penetration based on LightGBM","volume":"37","author":"Shaker","year":"2021","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111199_bib75","article-title":"Molecular mechanisms and therapeutic potential of lithium in Alzheimer's disease: repurposing an old class of drugs","volume":"15","author":"Shen","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111199_bib76","doi-asserted-by":"crossref","first-page":"688","DOI":"10.34172\/apb.2023.071","article-title":"Role of GSK-3\u03b2 inhibitors: new promises and opportunities for Alzheimer's disease","volume":"13","author":"Shri","year":"2023","journal-title":"Adv. Pharmaceut. Bull."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111199_bib77","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/bioinformatics\/bts200","article-title":"DelPhi web server v2: incorporating atomic-style geometrical figures into the computational protocol","volume":"28","author":"Smith","year":"2012","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111199_bib78","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.freeradbiomed.2004.02.081","article-title":"Short-term vitamin E intake fails to improve cognitive or psychomotor performance of aged mice","volume":"36","author":"Sumien","year":"2004","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111199_bib79","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/00498254.2013.845706","article-title":"Solvent-based formulations for intravenous mouse pharmacokinetic studies: tolerability and recommended solvent dose limits","volume":"44","author":"Thackaberry","year":"2014","journal-title":"Xenobiotica"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111199_bib80","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer's disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111199_bib81","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111199_bib82","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.tranon.2016.08.007","article-title":"Cyclin-dependent kinase 2 promotes tumor proliferation and induces radioresistance in glioblastoma","volume":"9","author":"Wang","year":"2016","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111199_bib83","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/bioinformatics\/btv607","article-title":"DelPhiPKa web server: predicting pKa of proteins, RNAs and DNAs","volume":"32","author":"Wang","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neuropharm.2026.111199_bib84","first-page":"1224","article-title":"Selective neuronal vulnerability to oxidative stress in the brain","volume":"2","author":"Wang","year":"2010","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111199_bib85","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0378-4274(95)03532-X","article-title":"Toxicity of iron and hydrogen peroxide: the Fenton reaction","volume":"82","author":"Winterbourn","year":"1995","journal-title":"Toxicol. Lett."},{"issue":"18","key":"10.1016\/j.neuropharm.2026.111199_bib86","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1523\/JNEUROSCI.4826-14.2015","article-title":"Assessment at the single-cell level identifies neuronal glutathione depletion as both a cause and effect of ischemia-reperfusion oxidative stress","volume":"35","author":"Won","year":"2015","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111199_bib87","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/minf.201200139","article-title":"Binding mechanism of inhibitors to CDK5\/p25 complex: free energy calculation and ranking aggregation analysis","volume":"32","author":"Wu","year":"2013","journal-title":"Mol. Inf."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111199_bib88","first-page":"122","article-title":"Synthesis and biological activities of benzothiazole derivatives: a review","volume":"1","author":"Yadav","year":"2023","journal-title":"Intell. Pharm."},{"key":"10.1016\/j.neuropharm.2026.111199_bib89","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neures.2014.12.015","article-title":"Cytoprotection against beta-amyloid (A\u03b2) peptide-mediated oxidative damage and autophagy by Keap1 RNAi in human glioma U87mg cells","volume":"94","author":"Youn","year":"2015","journal-title":"Neurosci. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111199_bib90","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"35","key":"10.1016\/j.neuropharm.2026.111199_bib91","doi-asserted-by":"crossref","first-page":"10572","DOI":"10.1021\/ja020243m","article-title":"Role of the catalytic triad and oxyanion hole in acetylcholinesterase catalysis: an ab initio QM\/MM study","volume":"124","author":"Zhang","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2026.111199_bib92","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neulet.2017.05.055","article-title":"Galantamine alleviates senescence of U87 cells induced by beta-amyloid through decreasing ROS production","volume":"653","author":"Zhang","year":"2017","journal-title":"Neurosci. Lett."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:53:32Z","timestamp":1792788812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":92,"alternative-id":["S0028390826003746"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111199","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A synthetic benzothiazole\u2013thiourea derivative with multi-target potential activity for Alzheimer's disease: Antioxidant properties and mechanistic insights","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111199"}}